Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population

Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. Case identification is currently made by real-time polymerase chain reaction (PCR) during the acute phase and largely restricted to healthcare laboratories. Serological assays are emerging but independent vali...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallett, S. J. C., Denny, S. J., Patel, A., Charani, E., Mughal, N., Stebbing, J., Davies, G. W., Moore, L. S. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955061/
https://www.ncbi.nlm.nih.gov/pubmed/33712679
http://dx.doi.org/10.1038/s41598-021-85247-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955061/
https://www.ncbi.nlm.nih.gov/pubmed/33712679
http://dx.doi.org/10.1038/s41598-021-85247-w

Ejemplares similares